RANDALL L BREAU

Allopathic & Osteopathic Physicians|Dermatology|MOHS-Micrographic Surgery LITTLE ROCK, AR NPI 1699804138

General Payments — all program years on this page

$1,095.19

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 43
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $328.95 across 16 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $328.9516

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
NOVARTIS PHARMACEUTICALS CORPORATION $162.4411
ORGANOGENESIS INC. $127.683
ABBVIE INC. $38.832

By program year

Program yearAmountRecords
2018 $78.191
2019 $209.883
2020 $11.951
2021 $53.062
2022 $132.647
2023 $280.5213
2024 $328.9516

Records — PY2024 (16)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1086690033 Novartis Pharmaceuticals Corporation $19.63 02/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086690035 Novartis Pharmaceuticals Corporation $1.55 02/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086690037 Novartis Pharmaceuticals Corporation $25.75 03/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086690039 Novartis Pharmaceuticals Corporation $21.56 04/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086690053 Novartis Pharmaceuticals Corporation $1.66 05/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086690055 Novartis Pharmaceuticals Corporation $22.83 07/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086690059 Novartis Pharmaceuticals Corporation $24.93 08/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086690061 Novartis Pharmaceuticals Corporation $2.29 08/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086690065 Novartis Pharmaceuticals Corporation $16.10 09/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086690067 Novartis Pharmaceuticals Corporation $4.10 09/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086690073 Novartis Pharmaceuticals Corporation $22.04 12/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103364711 ABBVIE INC. $20.70 07/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103364713 ABBVIE INC. $18.13 11/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145420905 Organogenesis Inc. $28.23 01/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145420907 Organogenesis Inc. $38.66 07/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145420909 Organogenesis Inc. $60.79 09/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.